SITABITE E 1MG 10/100 (Empagliflozin (10mg) + Sitagliptin (100mg))

SITABITE E 10/100 Tablet is utilized in the management of type 2 diabetes, primarily aimed at regulating blood glucose levels. The mechanism of action involves facilitating the kidneys’ ability to expel excess glucose while enhancing the body’s insulin sensitivity, leading to improved control of blood sugar. This medication is intended to be part of a comprehensive diabetes care plan, which includes adherence to a balanced diet and regular physical activity, to achieve optimal long-term management of the condition. For effective outcomes, it is essential to take SITABITE E 10/100 Tablet consistently as directed by a healthcare professional. Regular use not only helps maintain stable blood glucose levels but also minimizes the potential for severe complications associated with diabetes, including nerve damage, renal issues, and cardiovascular problems. It is critical not to discontinue use without medical advice, even if symptoms seem to improve, since diabetes is a chronic disorder requiring continuous attention. Patients should remain vigilant and engage in their prescribed treatment regimen to foster better health outcomes over time. Prior to initiation of therapy, individuals should inform their physician about any existing kidney or liver ailments, urinary tract infections, or cardiovascular conditions. This medication is not suitable for type 1 diabetes patients or those with a history of diabetic ketoacidosis and should be approached with care in older adults or those experiencing dehydration or diuretic therapy, as these could elevate the risk of hypotension.